The limits of functional reorganization in multiple sclerosis
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Investigating the brain at rest using functional MRI is a popular new method to investigate brain function in physiologic and pathologic conditions. Avoiding traditional task-based restrictions, it enables the researcher to investigate the entire brain with minimal burden and has therefore flourished recently, leading to the discovery of several consistent networks1 that are active in the healthy brain performing no task (i.e., at rest). One of these is the so-called default-mode network (DMN), which encompasses the medial prefrontal, anterior cingulate, posterior cingulate/precuneus, and lateral parietal cortices. The DMN was initially identified since it is frequently deactivated when performing active cognitive tasks, leading to the hypothesis that this network is involved in cognitive postprocessing at rest; supporting this idea is the finding that it is completely quiet in coma.2 Most current resting state studies focus on this network and have yielded a plethora of studies in a wide spectrum of neurologic diseases, like Alzheimer disease (AD), whereas multiple sclerosis (MS) has been notably absent until now.
Resting state studies alone cannot answer all questions regarding task-based functions. Combining resting state with task-based paradigms therefore allows for an optimal assessment of function in several disease states. Normal deactivation of regions of the DMN during tasks is, for example, present3 in early mild cognitive impairment (MCI) stages, combined with …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Long-term Safety and Efficacy of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease
Dr. Marianne de Visser and Dr. Maudy Theunissen
► Watch
Alert Me
Recommended articles
-
Article
Amyloid and cerebrovascular burden divergently influence brain functional network changes over timeJoanna Su Xian Chong, Hyemin Jang, Hee Jin Kim et al.Neurology, September 11, 2019 -
Article
Network Damage Predicts Clinical Worsening in Multiple SclerosisA 6.4-Year StudyMaria A. Rocca, Paola Valsasina, Alessandro Meani et al.Neurology: Neuroimmunology & Neuroinflammation, May 21, 2021 -
Articles
Large-scale neuronal network dysfunction in relapsing-remitting multiple sclerosisMaria A. Rocca, Paola Valsasina, Vittorio Martinelli et al.Neurology, September 05, 2012 -
Research Article
Longitudinal Network Changes and Conversion to Cognitive Impairment in Multiple SclerosisMarijn Huiskamp, Anand J.C. Eijlers, Tommy A.A. Broeders et al.Neurology, June 07, 2021